Opportunistic interventions for methamphetamine use: reducing the risks
dc.contributor.author | Pennay, Amy | |
dc.contributor.author | Lubman, D. | |
dc.contributor.author | Reichert, T. | |
dc.contributor.editor | Steve Allsop | |
dc.contributor.editor | Nicole Lee | |
dc.date.accessioned | 2017-01-30T14:59:11Z | |
dc.date.available | 2017-01-30T14:59:11Z | |
dc.date.created | 2015-03-03T20:14:25Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Pennay, A. and Lubman, D. and Reichert, T. 2012. Opportunistic interventions for methamphetamine use: reducing the risksin Allsop, S. and Lee, N. (ed), Perspectives on Amphetamine-Type Stimulants, pp. 241-253. Australia: IP Communications. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/42356 | |
dc.description.abstract |
Methamphetamine is the third most popular illicit drug in Australia. Over one million (6.3%) Australians report having ever tried methamphetamine, and approximately 3% are regular users (AHIW 2008). Around 11 % of regular users are likely to develop dependence to methamphetamine (equating to 73 000 Australians) (McKetin et al 2005a), underscoring the need for early detection and effective management of methamphetamine-related harms. However, methamphetamine users are less likely than other drug users to access specialist alcohol and other drug (AOD) treatment for their drug use (AIHW 2007; Klee & Morris 1994; Pennay & Lee 2009; Shearer & Gowing 2004; Wright et al 1999), highlighting the important role that other healthcare professionals (e.g. general practitioners (GPs), hospital staff and mental health workers) must play in the treatment of methamphetamine use/dependence. In this chapter, we discuss Steven, a methamphetamine user who presents to his local GP with problems related to methamphetamine use. In describing this case, important clinical and treatment issues are explored. | |
dc.publisher | IP Communications | |
dc.title | Opportunistic interventions for methamphetamine use: reducing the risks | |
dc.type | Book Chapter | |
dcterms.source.startPage | 241 | |
dcterms.source.endPage | 253 | |
dcterms.source.title | Perspectives on Amphetamine-Type Stimulants | |
dcterms.source.isbn | 9780980864991 | |
dcterms.source.place | Australia | |
dcterms.source.chapter | 28 | |
curtin.department | National Drug Research Institute (NDRI) | |
curtin.accessStatus | Fulltext not available |